Skip to content
June 26, 2022

Equity.Guru

Investment information for the new generation

CBDs

The Cannabis space has been garnering a lot of attention. Maybe not from the mainstream financial media, but definitely from the retail crowd. I cannot even begin to tell…
Tetra Bio-Pharma (TBP.T) received Health Canada’s approval for their amendment of a phase I study involving the safety profile of low and moderate doses of inhaled CBD. They’re conducting…
Is it time to buy Cannabis? Over the recent weeks, here on Equity Guru, I have been telling readers and discord members that the bottom may be in for…
Let’s be honest. 2021 wasn’t a great year for cannabis. We kicked off the year with some excitement and hope that the new Democrat administration would federally legalize cannabis….
It hasn’t been fun being invested in the Cannabis space recently. A lot of eyes have been on the US side of things. The catalyst being Federal deregulation. I…
In December 2018, we dropped an article about a company we’d spotted in the wild, a private cannabis company making moves in Africa and claiming they’d cracked the nut…
In this episode, we take a look at 4 Canadian cannabis stocks with potential. High Tide Cannabis (HITI.V), Heritage Cannabis Holding (CANN.C), Tetra Bio-Pharma (TBP.T) and VIVO Cannabis Inc.,…
What to say about Cannabis stocks. You give us some hope, and then pull the rug from under us. If you are a member of Equity Guru’s Free Trading…
Welcome to Equity.Guru’s Roundtable where our writers weigh in on the pros and cons of a spotlight company, break out where they see value, and help you avoid public…
Long time readers have been aware that, for some time, Equity.Guru has been a supporter of Canntab Therapeutics (PILL.C), but have been frustrated watching the company being slow on…